(Q47978757)

English

Prediction of Clinical Responses in a Simulated Phase III Trial of Crohn's Patients Administered the Antisense Phosphorothioate Oligonucleotide ISIS 2302: Comparison of Proposed Dosing Regimens

scientific article published on February 1, 2003

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12691536

Prediction of Clinical Responses in a Simulated Phase III Trial of Crohn's Patients Administered the Antisense Phosphorothioate Oligonucleotide ISIS 2302: Comparison of Proposed Dosing Regimens (English)

1 reference

10.1089/108729003764097340

https://api.crossref.org/works/10.1089/108729003764097340

23 December 2023

phase III clinical trial

0 references

1 reference

10.1089/108729003764097340

https://api.crossref.org/works/10.1089/108729003764097340

23 December 2023

1 reference

10.1089/108729003764097340

https://api.crossref.org/works/10.1089/108729003764097340

23 December 2023

author name string

Andrew Dorr

6

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12691536

Rosie Z. Yu

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12691536

23 December 2023

John Q. Su

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12691536

23 December 2023

John S. Grundy

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12691536

23 December 2023

Richard S. Geary

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12691536

23 December 2023

K. Lea Sewell

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12691536

23 December 2023

Arthur A. Levin

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12691536

23 December 2023

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12691536

23 December 2023

publication date

1 February 2003

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12691536

full work available at URL

http://www.liebertpub.com/doi/pdf/10.1089/108729003764097340

1 reference

10.1089/108729003764097340

https://api.crossref.org/works/10.1089/108729003764097340

23 December 2023

Oligonucleotides

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12691536

13

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12691536

1

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12691536

57-66

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12691536

Role of modelling and simulation in Phase I drug development

1

1 reference

10.1089/108729003764097340

https://api.crossref.org/works/10.1089/108729003764097340

23 December 2023

Journal of Pharmacology and Experimental Therapeutics

4

282

1173

author name string

GLOVER J.M.

publication date

1997

1 reference

10.1089/108729003764097340

https://api.crossref.org/works/10.1089/108729003764097340

23 December 2023

Height-weight tables

5

1 reference

10.1089/108729003764097340

https://api.crossref.org/works/10.1089/108729003764097340

23 December 2023

Journal of Pharmacology and Experimental Therapeutics

6

281

810

author name string

HENRY S.P.

publication date

1997

1 reference

10.1089/108729003764097340

https://api.crossref.org/works/10.1089/108729003764097340

23 December 2023

Simulation of clinical trials

7

1 reference

10.1089/108729003764097340

https://api.crossref.org/works/10.1089/108729003764097340

23 December 2023

Prediction of the outcome of a phase 3 clinical trial of an antischizophrenic agent (quetiapine fumarate) by simulation with a population pharmacokinetic and pharmacodynamic model.

9

1 reference

10.1089/108729003764097340

https://api.crossref.org/works/10.1089/108729003764097340

23 December 2023

Relative merits of the weight-corrected-for-height indices

10

1 reference

10.1089/108729003764097340

https://api.crossref.org/works/10.1089/108729003764097340

23 December 2023

Pharmacokinetic/pharmacodynamic studies in drug product development

11

1 reference

10.1089/108729003764097340

https://api.crossref.org/works/10.1089/108729003764097340

23 December 2023

Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis

12

1 reference

10.1089/108729003764097340

https://api.crossref.org/works/10.1089/108729003764097340

23 December 2023

Clinical trial simulation of docetaxel in patients with cancer as a tool for dosage optimization

14

1 reference

10.1089/108729003764097340

https://api.crossref.org/works/10.1089/108729003764097340

23 December 2023

A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease

15

1 reference

10.1089/108729003764097340

https://api.crossref.org/works/10.1089/108729003764097340

23 December 2023

Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease

16

1 reference

10.1089/108729003764097340

https://api.crossref.org/works/10.1089/108729003764097340

23 December 2023

Identifiers

10.1089/108729003764097340

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12691536

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/12691536

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47978757&oldid=2034912872"